245 related articles for article (PubMed ID: 20435659)
1. Upper-respiratory viral infection, biomarkers, and COPD exacerbations.
Kherad O; Kaiser L; Bridevaux PO; Sarasin F; Thomas Y; Janssens JP; Rutschmann OT
Chest; 2010 Oct; 138(4):896-904. PubMed ID: 20435659
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
3. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
4. Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children.
Kapur N; Mackay IM; Sloots TP; Masters IB; Chang AB
Arch Dis Child; 2014 Aug; 99(8):749-53. PubMed ID: 24819370
[TBL] [Abstract][Full Text] [Related]
5. Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital.
Biancardi E; Fennell M; Rawlinson W; Thomas PS
Intern Med J; 2016 Oct; 46(10):1160-1165. PubMed ID: 27515577
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
7. Time-course of upper respiratory tract viral infection and COPD exacerbation.
Stolz D; Papakonstantinou E; Grize L; Schilter D; Strobel W; Louis R; Schindler C; Hirsch HH; Tamm M
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31391222
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and risk factors of respiratory viral infection in acute exacerbation of chronic obstructive pulmonary disease].
Du XB; Ma X; Gao Y; Wen LF; Li J; Wang ZZ; Liu S
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Apr; 40(4):263-266. PubMed ID: 28395404
[No Abstract] [Full Text] [Related]
9. Differences in the spectrum of respiratory viruses and detection of human rhinovirus C in exacerbations of adult asthma and chronic obstructive pulmonary disease.
Kan-O K; Washio Y; Fujimoto T; Shiroyama N; Nakano T; Wakamatsu K; Takata S; Yoshida M; Fujita M; Matsumoto K
Respir Investig; 2022 Jan; 60(1):129-136. PubMed ID: 34580039
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease.
Ko FW; Chan PK; Chan RWY; Chan KP; Ip A; Kwok A; Ngai JC; Ng SS; On CT; Hui DS
Respir Res; 2019 Sep; 20(1):210. PubMed ID: 31519188
[TBL] [Abstract][Full Text] [Related]
11. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review.
Zwaans WA; Mallia P; van Winden ME; Rohde GG
J Clin Virol; 2014 Oct; 61(2):181-8. PubMed ID: 25066886
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review.
Mohan A; Chandra S; Agarwal D; Guleria R; Broor S; Gaur B; Pandey RM
Respirology; 2010 Apr; 15(3):536-42. PubMed ID: 20415983
[TBL] [Abstract][Full Text] [Related]
14. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
[TBL] [Abstract][Full Text] [Related]
15. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
16. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.
Rohde G; Wiethege A; Borg I; Kauth M; Bauer TT; Gillissen A; Bufe A; Schultze-Werninghaus G
Thorax; 2003 Jan; 58(1):37-42. PubMed ID: 12511718
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease.
Kwak HJ; Park DW; Kim JE; Park MK; Koo GW; Park TS; Moon JY; Kim TH; Sohn JW; Yoon HJ; Shin DH; Kim SH
Tohoku J Exp Med; 2016 Oct; 240(2):131-139. PubMed ID: 27725531
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Prognostic Factors of Respiratory Viral Infections in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Jang JG; Ahn JH; Jin HJ
Int J Chron Obstruct Pulmon Dis; 2021; 16():1265-1273. PubMed ID: 33994783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
